{"altmetric_id":2661780,"counts":{"readers":{"mendeley":37,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[51925],"posts_count":1},"total":{"posts_count":3},"twitter":{"unique_users_count":2,"unique_users":["7Journals","FionaPring"],"posts_count":2}},"selected_quotes":["Lenvatinib, an angiogenesis inhibitor targeting VEGFR\/FGFR, shows broad antitumor activity in... #BioMed #Journals"],"citation":{"altmetric_jid":"4f6fa4d03cf058f6100008a7","authors":["Yuji Yamamoto","Junji Matsui","Tomohiro Matsushima","Hiroshi Obaishi","Kazuki Miyazaki","Katsuji Nakamura","Osamu Tohyama","Taro Semba","Atsumi Yamaguchi","Sachi S Hoshi","Fusayo Mimura","Toru Haneda","Yoshio Fukuda","Jun-ichi Kamata","Keiko Takahashi","Masayuki Matsukura","Toshiaki Wakabayashi","Makoto Asada","Ken-ichi Nomoto","Tatsuo Watanabe","Zoltan Dezso","Kentaro Yoshimatsu","Yasuhiro Funahashi","Akihiko Tsuruoka"],"doi":"10.1186\/2045-824x-6-18","first_seen_on":"2014-09-06T22:01:58+00:00","issns":["2045-824X"],"issue":"1","journal":"Vascular Cell","last_mentioned_on":1411046921,"links":["http:\/\/www.vascularcell.com\/content\/6\/1\/18"],"pdf_url":"http:\/\/www.vascularcell.com\/content\/pdf\/2045-824X-6-18.pdf","pubdate":"2014-09-06T00:00:00+00:00","publisher":"BioMed Central Ltd","startpage":"18","title":"Lenvatinib, an angiogenesis inhibitor targeting VEGFR\/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage","type":"article","volume":"6","mendeley_url":"http:\/\/www.mendeley.com\/research\/lenvatinib-angiogenesis-inhibitor-targeting-vegfrfgfr-shows-broad-antitumor-activity-human-tumor-xen"},"altmetric_score":{"score":8.838,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":8.838},"context_for_score":{"all":{"total_number_of_other_articles":4507652,"mean":5.1453542744813,"rank":466245,"this_scored_higher_than_pct":89,"this_scored_higher_than":4041498,"rank_type":"exact","sample_size":4507652,"percentile":89},"similar_age_3m":{"total_number_of_other_articles":116215,"mean":8.1575017123586,"rank":16124,"this_scored_higher_than_pct":86,"this_scored_higher_than":100090,"rank_type":"exact","sample_size":116215,"percentile":86},"this_journal":{"total_number_of_other_articles":55,"mean":3.3048148148148,"rank":11,"this_scored_higher_than_pct":80,"this_scored_higher_than":44,"rank_type":"exact","sample_size":55,"percentile":80},"similar_age_this_journal_3m":{"total_number_of_other_articles":2,"mean":0.5,"rank":1,"this_scored_higher_than_pct":50,"this_scored_higher_than":1,"rank_type":"exact","sample_size":2,"percentile":50}}},"demographics":{"poster_types":{"member_of_the_public":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":1,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":1,"Student  > Doctoral Student":1,"Researcher":5,"Student  > Ph. D. Student":5,"Student  > Postgraduate":1,"Other":13,"Student  > Master":3,"Student  > Bachelor":6,"Professor":1},"by_discipline":{"Medicine and Dentistry":17,"Chemistry":1,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":6,"Linguistics":1,"Biochemistry, Genetics and Molecular Biology":7,"Unspecified":2,"Pharmacology, Toxicology and Pharmaceutical Science":2}}}},"posts":{"blogs":[{"title":"A new angiogenesis inhibitor targeting multiple tyrosine kinases offers new hope for treating tumors","url":"http:\/\/blogs.biomedcentral.com\/bmcblog\/2014\/09\/12\/a-new-angiogenesis-inhibitor\/","citation_ids":[2661780],"posted_on":"2014-09-12T08:00:00+00:00","summary":"A guest blog from co-Editor-in-Chief of Vascular Cell, Jan Kitajewski, in which he discusses the potential of using the newly developed lenvatinib as an anti-angiogenic therapy in the treatment of thyroid cancer.\nBlood vessels can be thought to function as","author":{"name":"BioMed Central blog","url":"http:\/\/blogs.biomedcentral.com\/bmcblog","description":"The Open Access Publisher"}}],"twitter":[{"url":"https:\/\/twitter.com\/7Journals\/status\/508374223962652672","license":"datasift","citation_ids":[2661780],"posted_on":"2014-09-06T22:00:34+00:00","author":{"name":"7Journals","image":"https:\/\/pbs.twimg.com\/profile_images\/323301047\/7journals-com_normal.jpg","description":"Online Edition of the #Journals and #Commentary","id_on_source":"7Journals","tweeter_id":"58580755","geo":{"lt":null,"ln":null},"followers":264},"tweet_id":"508374223962652672"},{"url":"https:\/\/twitter.com\/FionaPring\/status\/512594059022438401","license":"datasift","rt":["7Journals"],"citation_ids":[2661780],"posted_on":"2014-09-18T13:28:41+00:00","author":{"name":"Fiona Pring","url":"http:\/\/www.linkedin.com\/in\/fionapring","image":"https:\/\/pbs.twimg.com\/profile_images\/227148548\/twitpic_normal.jpg","description":"Biomedical science journal publishing industry. Currently Associate Publisher @BioMedCentral.  All views are my own.","id_on_source":"FionaPring","tweeter_id":"42061611","geo":{"lt":null,"ln":null},"followers":349},"tweet_id":"512594059022438401"}]}}